Pediatric Neurology, a prestigious journal published by Elsevier Science Inc, is a leading resource in the field of child neurology and developmental neurosciences. With an impressive impact factor and categorization in the Q1 and Q2 quartiles across several relevant fields, including Pediatrics, Neurology, and Developmental Neuroscience, this journal is essential for researchers and healthcare professionals focused on pediatric neurological disorders. Since its inception in 1985, it has provided a platform for high-quality research, clinical studies, and reviews that drive advancements in diagnosis, treatment, and understanding of neurological conditions in children. Although the journal does not currently offer open access, it maintains a robust reputation in the academic community, bolstered by its prominent ranking in Scopus metrics. By engaging with the latest findings published in Pediatric Neurology, readers will gain vital insights that contribute to improving pediatric healthcare outcomes in neurology and neuroscience.

Neuropsychiatric Disease and Treatment, published by DOVE MEDICAL PRESS LTD, is a prominent open access journal dedicated to advancing the field of neuropsychiatry. Since its inception in 2009, this journal has provided a platform for the dissemination of high-quality research on innovative therapies and treatments for neuropsychiatric disorders. With an impressive Q2 ranking in Psychiatry and Mental Health and a Q3 ranking in Biological Psychiatry as of 2023, it holds a reputable position within the scholarly community, reflecting its commitment to impactful research. The journal's open access model ensures widespread accessibility, fostering collaboration and dialogue among researchers, clinicians, and students worldwide. The journal accepts a variety of article types, including original research, reviews, and case studies, encompassing a range of topics from pathophysiology to therapeutic advancements. With its base in New Zealand and a Scopus rank placing it within the 69th percentile of Psychiatry and Mental Health, Neuropsychiatric Disease and Treatment is an essential resource for those dedicated to understanding and treating the complexities of neuropsychiatric conditions.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Human Gene is an innovative open access journal published by ELSEVIER, dedicated to the ever-evolving field of genetics. Established in 2022, this journal serves as a vital resource for researchers, professionals, and students alike, aiming to facilitate the dissemination of groundbreaking research and advancements in both basic and clinical genetics. With an ISSN of 2773-0441, Human Gene focuses on providing a platform for high-quality studies that investigate genetic mechanisms, their implications in health and disease, and novel therapeutic strategies. The journal currently holds a Q4 ranking in both Genetics and Clinical Genetics categories, reflecting its emerging status within the scientific community, and strives to enhance its impact to better serve an engaged audience. With its base in Amsterdam, Netherlands, Human Gene is committed to making research accessible through its open access model, inviting contributions that advance our understanding of human genetics and foster collaboration across disciplines.

JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

The Egyptian Journal of Medical Human Genetics is a distinguished Open Access journal published by SPRINGER NATURE, dedicated to advancing the field of medical human genetics. With an ISSN of 1110-8630 and an E-ISSN of 2090-2441, this journal serves as a vital platform for researchers, professionals, and students who are committed to the exploration of genetic implications on human health. Since its inception in 2010, it has become a growing repository of knowledge, significantly contributing to the discourse in clinical genetics, despite currently being ranked in the Q4 quartile of its category in 2023. The journal embraces an open access model, ensuring widespread visibility and accessibility of published research, thereby fostering collaboration and innovation in the field. The journal is not only aimed at disseminating findings but also at encouraging the dialogue around genetic research developments, making it an essential resource for anyone interested in the nuances of genetics and its impact on medicine.

Journal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.

PSYCHIATRY RESEARCH is a leading journal published by Elsevier Ireland Ltd, dedicated to advancing the field of psychiatry and mental health through the dissemination of rigorous research. With an impressive impact factor and categorized in the top quartile (Q1) of both Biological Psychiatry and Psychiatry and Mental Health in 2023, this journal ranks 14th in the field of Medicine _ Psychiatry and Mental Health out of 567 journals, and 4th in Neuroscience _ Biological Psychiatry out of 51, showcasing its influence and quality. Since its inception in 1979, PSYCHIATRY RESEARCH has provided a platform for innovative studies, clinical trials, and comprehensive reviews aimed at understanding the complexities of mental health disorders. Although it operates under a traditional access model, the journal remains committed to making vital research available to the academic community, ensuring that both seasoned professionals and budding researchers have access to groundbreaking findings. Positioned as a hub for psychiatric research, it caters to a diverse audience including clinicians, psychologists, and students, empowering them to contribute to the evolving landscape of mental health care.

The Journal of Genetics and Genomics, published by SCIENCE PRESS in China, stands as a significant contributor to the fields of Genetics and Molecular Biology. With an ISSN of 1673-8527 and E-ISSN 1873-5533, this esteemed journal has achieved a remarkable reputation, holding a prestigious Q1 ranking in both Genetics and Molecular Biology as of 2023. This journal not only showcases pioneering research but also fosters vital discussions on contemporary challenges and innovations within genomic sciences. As part of its commitment to facilitating scientific advancement, the journal encompasses a range of research articles, reviews, and short communications, all aiming to illuminate the complexities of genetic structures and functions from 2007 to 2024. Researchers, professionals, and students alike are encouraged to engage with its content, which ranks favorably in Scopus—placing it within the top tier of its categories. Join the community of academic excellence and explore the latest findings that shape our understanding of genomics.

The EUROPEAN JOURNAL OF HUMAN GENETICS, published by SpringerNature, stands as a preeminent platform in the field of genetics and clinical genetics. Established in 1993, this prestigious journal, with an ISSN of 1018-4813 and an E-ISSN of 1476-5438, has consistently maintained its position in the Q1 quartile for both Genetics and Clinical Genetics categories as of 2023, reflecting its significant contributions to the field. Its impact is further underscored by its impressive Scopus rankings, placing it in the 92nd percentile among clinical genetics journals. The journal aims to disseminate cutting-edge research, case studies, and reviews that advance our understanding of human genetics, promoting collaboration and innovation among researchers, professionals, and students alike. While it does not currently offer open access, the journal provides substantial value through its rigorous peer review process and commitment to quality. As it continues to shape the future of genetic research through 2024 and beyond, the EUROPEAN JOURNAL OF HUMAN GENETICS remains an essential resource for those dedicated to exploring the complexities of human heredity.